Dr. Cyrus Nasserian, MD

Dr. Nasserian practices at Glendora Hospital in Glendora, California, part of College Health.

Dr. Nasserian's NPI, 1154692556, was assigned on January 18, 2012. Dr. Nasserian graduated from American University of the Caribbean School of Medicine in 2009. Dr. Nasserian holds California license A122271.

Dr. Nasserian's primary practice is Glendora Hospital, at 150 West Route 66, Glendora, CA 91740 in Los Angeles County. The practice phone is (626) 852-5050. Dr. Nasserian also practices at Glendora Community Hospital, 130 W Route 66, Glendora, CA 91740.

Dr. Nasserian's primary practice is Glendora Hospital in Glendora, California, part of College Health. Dr. Nasserian is also affiliated with Emanate Health Inter-Community Hospital. The medical group on file is California Psychiatric Group. Dmand AI also links Dr. Nasserian to 1 more hospital, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nasserian practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Nasserian's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Nasserian is board certified in addiction medicine by the American Board of Preventive Medicine. Dr. Nasserian is licensed in California.

Dmand AI lists anxiety, bipolar disorder, dementia, depression, non-alzheimer's dementia (chronic), psychoses and schizophrenia among the conditions Dr. Nasserian treats.

CMS data shows 2,523 Medicare services from Dr. Nasserian across 10 procedure codes in 2024, for 428 Medicare patients. Medicare paid $189,586 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 428 Medicare patients who saw Dr. Nasserian in 2024. The largest group is under 65, with 165 patients. 75% of them have high blood pressure, and 75% have mood disorders. 86% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nasserian's median patient age at 45, with 51% women.

In 2024, Dr. Nasserian wrote 701 Medicare Part D claims for 133 patients. 96% of them were for generic drugs. CMS names the drug for 469 of them, across 19 drugs with 11 or more claims each, at $7,982 in total drug cost. In 2023, CMS named 996 claims across 31 drugs.

Dr. Nasserian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 567 general payments to Dr. Nasserian from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $22,671.

Dr. Nasserian graduated from American University of the Caribbean School of Medicine in 2009.

Dr. Nasserian is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.